National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings, 26104-26105 [06-4149]
Download as PDF
26104
Federal Register / Vol. 71, No. 85 / Wednesday, May 3, 2006 / Notices
Place: Gaithersburg Hilton, 620 Perry
Parkway, Gaithersburg, MD 20877.
Contact Person: Lalita D. Palekar, PhD,
Scientific Review Administrator, Special
Review and Resources Branch, Division of
Extramural Activities, National Cancer
Institute, National Institutes of Health, 6116
Executive Boulevard, Room 8105, Bethesda,
MD 20892–7405, (301) 496–7575.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: April 26, 2006.
David Clary,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–4145 Filed 5–2–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Research
Resources; Notice of Closed Meetings
jlentini on PROD1PC65 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Research Resources Special Emphasis Panel,
Loan Repayment Program SEP.
Date: May 25, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Mohan Viswanathan, PhD,
Deputy Director, Office of Review, NCRR,
National Institutes of Health, 6701
Democracy Blvd., Room 1084, MSC 4874, 1
Democracy Plaza, Bethesda, MD 20892–4874,
301–435–0829, mv10f@nih.gov.
Name of Committee: National Center for
Research Resources Special Emphasis Panel,
GCRC K23 SEP.
Date: June 1, 2006.
VerDate Aug<31>2005
17:19 May 02, 2006
Jkt 208001
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Guo Zhang, PhD, Scientific
Review Administrator, National Center for
Research Resources/OR, National Institutes
of Health, 6701 Democracy Boulevard, 1
Democracy Plaza, Rm. 1064, Bethesda, MD
20892–4874, 301–435–0812.
zhanggu@mail.nih.gov.
Name of Committee: National Center for
Research Resources Initial Review Group,
Comparative Medicine Review Committee.
Date: June 6–7, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Double Tree Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: John R. Glowa, PhD,
Scientific Review Administrator, Office of
Review, National Center for Research
Resources, 6701 Democracy Boulevard, Room
1078—MSC 4874, Bethesda, MD 20892–4874,
301–435–0807, glowaj@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research; 93.371, Biomedical
Technology; 93.389, Research Infrastructure,
93.306, 93.333, National Institutes of Health,
HHS)
Dated: April 25, 2006.
David Clary,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–4146 Filed 5–2–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute clearly unwarranted
invasion of personal privacy.
Name of Committee: Training Grant and
Career Development Review Committee.
Date: May 11–12, 2006.
Time: 8 a.m. to 5 p.m.
PO 00000
Frm 00087
Fmt 4703
Sfmt 4703
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: Raul A. Saavedra, PhD,
Scientific Review Administrator, Scientific
Review Branch, Division of Extramural
Research, NINDS/NIH/DHHS, NSC; 6001
Executive Blvd., Ste. 3208, Bethesda, MD
20892–9529, 301–496–9223,
saavedrrninds.nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Initial
Review Group Neurological Sciences and
Disorders C.
Date: June 22–23, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Latham Hotel, 3000 M Street, NW.,
Washington, DC 20007.
Contact Person: Andrea Sawczuk, DDS,
PhD, Scientific Review Administrator,
Scientific Review Branch, Division of
Extramural Research, NINDS/NIH/DHHS,
6001 Executive Boulevard, Room #3208,
Bethesda. MD 20892, 301–496–0660,
sawczukzninds.nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Initial
Review Group, Neurological Sciences and
Disorder K.
Date: June 22–23, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Grand Hyatt-Washington Center,
1000 H St., NW., Washington, DC 20001.
Contact Person: Katherine M. Woodbury,
PhD, Scientific Review Administrator,
Scientific Review Branch, NINDS/NIH/
DHHS, Neuroscience Center, 6001 Executive
Blvd, Suite 3208, MSC 9529, Bethesda, MD
20892–9529, 301–496–9223.
Name of Committee: National Institutes of
Neurological Disorders and Stroke Initial
Review Group, Neurological Sciences and
Disorders A.
Date: June 22–23, 2006.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Fairmont Washington, DC.,
2401 M Street, NW., Washington, DC 20037.
Contact Person: Richard D. Crosland, PhD,
Scientific Review Administrator, Scientific
Review Branch, Division of Extramural
Research, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd, Suite 3208,
MSC 9529, Bethesda, MD 20892–9529, 301–
496–9223.
Name of Committee: National Institute of
Neurological Disorders and Stroke Initial
Review Group Neurological Sciences and
Disorders B.
Date: June 22–23, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Savoy Suites Hotel, 2505 Wisconsin
Avenue, NW., Washington, DC 20007.
Contact Person: W. Ernest Lyons, PhD,
Scientific Review Administrator, Scientific
Review Branch, NINDS/NIH/DHHS,
Neuroscience Center, 6001 Executive Blvd.,
E:\FR\FM\03MYN1.SGM
03MYN1
Federal Register / Vol. 71, No. 85 / Wednesday, May 3, 2006 / Notices
Suite 3208, MSC 9529, Bethesda, MD 20892–
9529, 301–496–4056.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: April 25, 2006.
David Clary,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–4149 Filed 5–2–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Meeting
jlentini on PROD1PC65 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Arthritis and Musculoskeletal
and Skin Diseases Advisory Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Arthritis and
Musculoskeletal and Skin Diseases Advisory
Council.
Date: May 23, 2006.
Open: 8:30 a.m. to 12 p.m.
Agenda: This meeting will be open to the
public to discuss administrative details
relating to council business and special
reports.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 6, Bethesda, MD 20892.
Closed: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 6, Bethesda, MD 20892.
VerDate Aug<31>2005
17:19 May 02, 2006
Jkt 208001
Contact Person: Cheryl Kitt, PhD, Director,
Extramural Program, National Institute of
Arthritis and Musculoskeletal and Skin
Diseases, 1 Democracy Blvd., Suite 800,
Bethesda, MD 20892, 301–594–2463,
kittc@niams.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Dated: April 26, 2006.
David Clary,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–4150 Filed 5–2–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Mesenchymal Stem Cells.
Date: May 3, 2006.
Time: 8:30 a.m. to 9 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
PO 00000
Frm 00088
Fmt 4703
Sfmt 4703
26105
Contact Person: William C. Benzing, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5206,
MSC 7846, Bethesda, MD 20892, (301) 435–
1254, benzingw@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Surgical Sciences,
Biomedical Imaging and Bioengineering
Integrated Review Group, Bioengineering,
Technology and Surgical Sciences Study
Section.
Date: May 22–23, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Clarion Hotel Bethesda Park, 8400
Wisconsin Ave., Bethesda, MD 20814.
Contact Person: Dharam S. Dhindsa, DVM,
PhD, Scientific Review Administrator, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5110,
MSC 7854, Bethesda, MD 20892, (301) 435–
1174, dhindsad@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, PAR–04–
023: Bioengineering Research Partnerships.
Date: May 23, 2006.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Silver Spring, 8727 Colesville
Road, Silver Spring, MD 20910.
Contact Person: Behrouz Shabestari, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5106,
MSC 7854, Bethesda, MD 20892, (301) 435–
2409, shabestb@csr.nih.gov.
Name of Committee: Infectious Diseases
and Microbiology Integrated Review Group,
Pathogenic Eukaryotes Study Section.
Date: June 8–9, 2006.
Time: 8:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn Georgetown, 2101
Wisconsin Avenue, NW., Washington, DC
20007.
Contact Person: Jean Hickman, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3194,
MSC 7808, Bethesda, MD 20892, (301) 435–
1146, hickmanj@csr.nih.gov.
Name of Committee: Surgical Sciences,
Biomedical Imaging and Bioengineering
Integrated Review Group, Surgery,
Anesthesiology and Trauma Study Section.
Date: June 14–15, 2006.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn Select Bethesda, 8120
Wisconsin Ave., Bethesda, MD 20814.
Contact Person: Weihua Luo, PhD., M.D.,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5114,
MSC 7854, Bethesda, MD 20892, (301) 435–
1170, luow@csr.nih.gov.
E:\FR\FM\03MYN1.SGM
03MYN1
Agencies
[Federal Register Volume 71, Number 85 (Wednesday, May 3, 2006)]
[Notices]
[Pages 26104-26105]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-4149]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute clearly unwarranted invasion of personal privacy.
Name of Committee: Training Grant and Career Development Review
Committee.
Date: May 11-12, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD
20814.
Contact Person: Raul A. Saavedra, PhD, Scientific Review
Administrator, Scientific Review Branch, Division of Extramural
Research, NINDS/NIH/DHHS, NSC; 6001 Executive Blvd., Ste. 3208,
Bethesda, MD 20892-9529, 301-496-9223, saavedrrninds.nih.gov.
Name of Committee: National Institute of Neurological Disorders
and Stroke Initial Review Group Neurological Sciences and Disorders
C.
Date: June 22-23, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Latham Hotel, 3000 M Street, NW., Washington, DC 20007.
Contact Person: Andrea Sawczuk, DDS, PhD, Scientific Review
Administrator, Scientific Review Branch, Division of Extramural
Research, NINDS/NIH/DHHS, 6001 Executive Boulevard, Room
3208, Bethesda. MD 20892, 301-496-0660,
sawczukzninds.nih.gov.
Name of Committee: National Institute of Neurological Disorders
and Stroke Initial Review Group, Neurological Sciences and Disorder
K.
Date: June 22-23, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Grand Hyatt-Washington Center, 1000 H St., NW.,
Washington, DC 20001.
Contact Person: Katherine M. Woodbury, PhD, Scientific Review
Administrator, Scientific Review Branch, NINDS/NIH/DHHS,
Neuroscience Center, 6001 Executive Blvd, Suite 3208, MSC 9529,
Bethesda, MD 20892-9529, 301-496-9223.
Name of Committee: National Institutes of Neurological Disorders
and Stroke Initial Review Group, Neurological Sciences and Disorders
A.
Date: June 22-23, 2006.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: The Fairmont Washington, DC., 2401 M Street, NW.,
Washington, DC 20037.
Contact Person: Richard D. Crosland, PhD, Scientific Review
Administrator, Scientific Review Branch, Division of Extramural
Research, NINDS/NIH/DHHS, Neuroscience Center, 6001 Executive Blvd,
Suite 3208, MSC 9529, Bethesda, MD 20892-9529, 301-496-9223.
Name of Committee: National Institute of Neurological Disorders
and Stroke Initial Review Group Neurological Sciences and Disorders
B.
Date: June 22-23, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Savoy Suites Hotel, 2505 Wisconsin Avenue, NW.,
Washington, DC 20007.
Contact Person: W. Ernest Lyons, PhD, Scientific Review
Administrator, Scientific Review Branch, NINDS/NIH/DHHS,
Neuroscience Center, 6001 Executive Blvd.,
[[Page 26105]]
Suite 3208, MSC 9529, Bethesda, MD 20892-9529, 301-496-4056.
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS)
Dated: April 25, 2006.
David Clary,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-4149 Filed 5-2-06; 8:45 am]
BILLING CODE 4140-01-M